Avanos Medical (NYSE:AVNS) Reaches New 1-Year Low – What’s Next?

Shares of Avanos Medical, Inc. (NYSE:AVNS) hit a new 52-week low during trading on Monday . The stock traded as low as $15.90 and last traded at $16.00, with a volume of 22944 shares trading hands. The stock had previously closed at $16.08.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.

Avanos Medical Stock Performance

The firm has a market cap of $735.31 million, a P/E ratio of 47.06 and a beta of 0.95. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The business’s 50-day simple moving average is $19.70 and its 200 day simple moving average is $21.32.

Institutional Investors Weigh In On Avanos Medical

A number of large investors have recently made changes to their positions in the company. Paradice Investment Management LLC boosted its holdings in shares of Avanos Medical by 5.4% in the second quarter. Paradice Investment Management LLC now owns 1,344,949 shares of the company’s stock worth $26,791,000 after buying an additional 69,389 shares during the last quarter. Geode Capital Management LLC raised its position in Avanos Medical by 1.5% in the third quarter. Geode Capital Management LLC now owns 1,054,162 shares of the company’s stock worth $25,337,000 after acquiring an additional 16,065 shares during the period. Foundry Partners LLC boosted its stake in shares of Avanos Medical by 1.1% during the 3rd quarter. Foundry Partners LLC now owns 163,030 shares of the company’s stock worth $3,918,000 after acquiring an additional 1,800 shares during the last quarter. AQR Capital Management LLC grew its position in shares of Avanos Medical by 21.0% during the 2nd quarter. AQR Capital Management LLC now owns 146,983 shares of the company’s stock valued at $2,875,000 after acquiring an additional 25,467 shares during the period. Finally, FMR LLC increased its stake in shares of Avanos Medical by 34.6% in the 3rd quarter. FMR LLC now owns 133,844 shares of the company’s stock worth $3,216,000 after purchasing an additional 34,421 shares in the last quarter. 95.17% of the stock is currently owned by institutional investors.

About Avanos Medical

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.